Promoter holding
64.27%
PB
Peerless Biotech Private Limited - Due diligence report
A 360° intelligence report on Peerless Biotech: trust score, financial health, credit view, compliance, directors, growth and distress signa…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Peerless Biotech — 360° Intelligence Report
Generated from MCA filings & public records90/100
Trust Score
Low Risk
Peerless Biotech is assessed as Low Risk with a Trust Score of 90/100. Peerless Biotech is an active private limited indian non-government company incorporated in 2001, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.
Report generated on 07 Aug 2026 from the latest processed filings. Peerless Biotech Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
90/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
95/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
80/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
80/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
70/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 95/100 Low Risk
- Liabilities ≈ 38% EBITDA - serviceable.
- No open charges - unencumbered balance sheet.
- Moderate gearing (D/E 1.42).
- Profitable - internal accruals available.
Charges position: 0 open (-) · 3 satisfied (22.10 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Hdfc Bank Limited | 2 | 48.0 cr |
| Bank Of Maharashtra | 1 | 48.0 cr |
Compliance Score: 100/100 Low Risk
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- 1 active GST registration(s).
05
Director Intelligence
Stability score: 80/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| VINAYAK VAIKUNTH BHAT | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PRABHAT AGRAWAL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SAMBIT MOHANTY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SASIDHARAN MOHAN KUMAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PREM SETHI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Sasidharan Mohan Kumar | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Sankar Varadharajan | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Raghunathan Sucharithra | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 8 directors on the board.
- No disqualified or deactivated DINs.
- 8 director exits in 3 years - high churn.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2023 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
1
Group entities
1
Capital events
1 allotment(s) · 4 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Euro Diagnostic Systems Private Limited | Subsidiary Company | 74.00% |
Key managerial personnel: VINAYAK VAIKUNTH BHAT (Managing Director) · SASIDHARAN MOHAN KUMAR (Whole-time director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 80 · Distress 70
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
Asset base grew 24% - capacity expansion.
EPFO headcount growing - hiring signal.
Operating for 25+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Outside liabilities up 0.86 in a year.
8 director exits within 2 years.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence88/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment95/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance record supports lending.
Investor view86/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 3 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events17 Sep 2025
Last AGM held
Annual general meeting
16 Sep 2025
Director ceased
SAMBIT MOHANTY
Director ceased
Sankar Varadharajan
Director ceased
Raghunathan Sucharithra
25 Aug 2025
Charge satisfied
Hdfc Bank Limited
10 Apr 2025
Director appointed
SAMBIT MOHANTY (Director)
31 Mar 2025
Latest balance sheet
Filed with ROC
19 Nov 2024
Charge satisfied
Hdfc Bank Limited
09 Nov 2024
Director appointed
Sankar Varadharajan (Director)
Director appointed
Raghunathan Sucharithra (Director)
29 Sep 2024
Director ceased
VENKATARAMANA RAM CHEBOLU
Director ceased
PRABHAT AGRAWAL
Director ceased
PREM SETHI
14 Sep 2024
Director appointed
Sasidharan Mohan Kumar (Ceo)
16 Aug 2024
Director appointed
PRABHAT AGRAWAL (Director)
10
Key Observations
Auto-generated from the data aboveRevenue grew 61% over the last 4 financial year(s).
Net profit margin moved from 38% to 1.42.
Debt-to-equity stands at 2.1x - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
8 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
All 3 registered charge(s) stand satisfied - past borrowings repaid.
Operates a group structure with 1 subsidiary(ies) - assess on a consolidated basis.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Taozen Technology Private Limited | U26100GJ2022PTC129358 | Daskroi, Gujarat, India |
| Frimline | U15130GJ2017PTC095323 | Prahlad Nagar Cross Rd, Gujarat, India |
| Ramjanki Agritrade Private Limited | U01100MP2018PTC045067 | Ujjain, Madhya Pradesh, India |
| Bansal Associates Private Limited | U10200AS1993PTC004027 | Guwahati, Assam, India |
| Micromax Informatics | U00000DL2000PLC104823 | New Delhi, Delhi, India |
| Navnidhi Ferromet Private Limited | U27101MH2009PTC193336 | Mumbai, Maharashtra, India |
| Raymond Consumer Care | L74999MH2018PLC316288 | Aurangabad, Maharashtra, India |
| M.S.R.Iron And Steel Industries India Private Limited | U27106TZ2009PTC015219 | Coimbatore, Tamil Nadu, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Peerless Biotech before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Peerless Biotech: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 95/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 80/100, margin trends, ownership structure and peer set for Peerless Biotech - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 90/100, distress signals and MSME payment-delay disclosures - know whether Peerless Biotech pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Peerless Biotech - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Peerless Biotech an active company?
Peerless Biotech has MCA status “Active” with a compliance score of 100/100 (Low Risk).
Is Peerless Biotech financially healthy?
Peerless Biotech has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.
Should I do business with Peerless Biotech?
Its overall Trust Score is 90/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Peerless Biotech?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 8 active director(s) are on record.
Does Peerless Biotech have loans or charges against its assets?
No open charges - all 3 registered charge(s) stand satisfied, indicating past borrowings were repaid.
Is Peerless Biotech up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).
Is it risky to lend to Peerless Biotech?
Its Credit Risk Score is 95/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
